🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-520498-38-00
Authorised Phase I

Evaluation of the bioequivalence of two intravaginal gel preparations containing 90 mg progesterone

2025-520498-38-00 · tracked via the Priya Life Science EU tracker
Sponsor
CCDRD Cooperative Clinical Drug Research and Development AG, Ioulia And Irene Tseti Pharmaceutical Laboratories S.A.
Sponsor type
Pharmaceutical company, Pharmaceutical company
Therapeutic area
Physiological processes
Decision date
10/09/2026
Enrollment target
48
Sites
Bulgaria

Condition studied

No therapeutic indication in the current trial with healthy volunteers.

Eligibility

Age group
18-64 years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-520498-38-00 on CTIS ↗ ← All trials in the EU